Technology
Health
Medical

AngioDynamics

$21.88
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.05 (0.23%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell AngioDynamics and other stocks, options, ETFs, and crypto commission-free!

About

AngioDynamics, Inc. engages in the development, manufacture, and sale of medical devices for vascular access, surgery, peripheral vascular disease, and oncology. It offers ablation systems, fluid management systems, vascular access, angiographic, drainage. thrombolytic, and venous products. Read More The company was founded by Eamonn P. Hobbs in 1988 and is headquartered in Latham, NY.

Employees
1,145
Headquarters
Latham, New York
Founded
1988
Market Cap
818.75M
Price-Earnings Ratio
45.98
Dividend Yield
0.00
Average Volume
218.98K
High Today
$22.23
Low Today
$21.72
Open Price
$21.84
Volume
54.07K
52 Week High
$24.49
52 Week Low
$15.26

Collections

Technology
Health
Medical
Medical Devices
US
North America

News

TradingNewsNowMar 21

Stock Valuation: AngioDynamics (NASDAQ: ANGO)

AngioDynamics is in the healthcare sector and is in the medical instruments and equipment industry. The company CEO is James C. Clemmer. AngioDynamics Inc designs, manufactures and sells medical, surgical and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Previous Intraday Trading Performance: The ANGO stock showed a previous change of 0.00% with an open at 22.10 and a close of 22.14. It reached a...

5
Simply Wall StMar 14

Is AngioDynamics, Inc. (NASDAQ:ANGO) Struggling With Its 3.9% Return On Capital Employed?

Today we’ll look at AngioDynamics, Inc. (NASDAQ:ANGO) and reflect on its potential as an investment. In particular, we’ll consider its Return On Capital Employed (ROCE), as that can give us insight into how profitably the company is able to employ capital in its business. First of all, we’ll work out how to calculate ROCE. Next, we’ll compare it to others in its industry. And finally, we’ll look at how its current liabilities are impacting its ROCE. What is Return On Capital Employed (ROCE)? ROCE is a me...

13
Associated PressMar 8

AngioDynamics Wins Patent Infringement Dispute With Bard

LATHAM, N.Y.--(BUSINESS WIRE)--Mar 8, 2019--AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease and oncology, today announced that the United States District Court for the District of Delaware, on day four of a jury trial at the close of C.R. Bard’s case (Plaintiff), granted judgement as a matter of law under rule 50(a) in favor of AngioDynamics, dismissing Bard’s suit alleging that certain of AngioDynamics...

18

Earnings

$0.12
$0.16
$0.21
$0.25
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
$0.22 per share
Actual
Available Apr 2, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.